[
  {
    "ts": null,
    "headline": "Bio-Techne, USP Partner to Enhance Monoclonal Antibody, Gene Therapy Development",
    "summary": "Bio-Techne Corporation (NASDAQ:TECH) is one of the best S&P 500 stocks with huge upside potential. On June 24, Bio-Techne Corporation announced a distribution agreement with the US Pharmacopeia/USP. The collaboration allows Bio-Techne to sell USP monoclonal antibody/mAb and recombinant adeno-associated virus/AAV reference standards alongside its analytical solutions, like the Maurice system, to support the global […]",
    "url": "https://finnhub.io/api/news?id=47426960948962db49f4344d701a3d5fc362ee87b28c86e18d6d80f4db3788f1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750884391,
      "headline": "Bio-Techne, USP Partner to Enhance Monoclonal Antibody, Gene Therapy Development",
      "id": 135531094,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TECH",
      "source": "Yahoo",
      "summary": "Bio-Techne Corporation (NASDAQ:TECH) is one of the best S&P 500 stocks with huge upside potential. On June 24, Bio-Techne Corporation announced a distribution agreement with the US Pharmacopeia/USP. The collaboration allows Bio-Techne to sell USP monoclonal antibody/mAb and recombinant adeno-associated virus/AAV reference standards alongside its analytical solutions, like the Maurice system, to support the global […]",
      "url": "https://finnhub.io/api/news?id=47426960948962db49f4344d701a3d5fc362ee87b28c86e18d6d80f4db3788f1"
    }
  },
  {
    "ts": null,
    "headline": "Bio-Techne Corp. stock outperforms competitors on strong trading day",
    "summary": "Bio-Techne Corp. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=2c1671b324afae7072bcb2ab6790ebc2be914f1bd55d89688982d9d65ba08c88",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750869000,
      "headline": "Bio-Techne Corp. stock outperforms competitors on strong trading day",
      "id": 135613794,
      "image": "",
      "related": "TECH",
      "source": "MarketWatch",
      "summary": "Bio-Techne Corp. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=2c1671b324afae7072bcb2ab6790ebc2be914f1bd55d89688982d9d65ba08c88"
    }
  },
  {
    "ts": null,
    "headline": "Is Bio-Techne Stock Underperforming the Nasdaq?",
    "summary": "Bio-Techne has underperformed the Nasdaq over the past year, but analysts are moderately optimistic about the stock’s prospects.",
    "url": "https://finnhub.io/api/news?id=54cfa71a9eec96220571b301f37afeafa26a1bb2d892d0192e68193109b25f97",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750855490,
      "headline": "Is Bio-Techne Stock Underperforming the Nasdaq?",
      "id": 135525488,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TECH",
      "source": "Yahoo",
      "summary": "Bio-Techne has underperformed the Nasdaq over the past year, but analysts are moderately optimistic about the stock’s prospects.",
      "url": "https://finnhub.io/api/news?id=54cfa71a9eec96220571b301f37afeafa26a1bb2d892d0192e68193109b25f97"
    }
  }
]